Assurity MRI and Endurity MRI Pacemakers, Tendril MRI Lead, MRI Activator, Merlin PCS Programer Software

Implantable Pulse Generator, Pacemaker (non-crt)

FDA Premarket Approval P140033

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the mr conditional pacemaker system (which includes the assurity mri (models pm 1272, pm 2272) and endurity mri (models pm 1172, pm 2172) pacemakers, tendril mri lead (model lpa 1200m), mri activator (model ex4000), merlin pcs programmer software (model 3330 v 22. 1. 1), merlin. Net mn5000 7. 4d, and merlin@home ex2000 8. 2. 2). Implantation of a single-chamber pulse generator or dual-chamber pulse generator is indicated for in one or more of the following permananent conditions:1) syncope;2) presyncope;3) fatigue;4) disorientation; or5) any combination of those symptomsmr conditional pulse generator is safe for use in the mri environment when used as a complete mr conditional pacing system, and according to the instructions in the mri procedure information document for the st. Jude medical mr conditional pacing system. Rate-modulated pacing is indicated for patients with chronotropic incompetence, and for those who would benefit from increased stimulation rates concurrent with physical activity. Chronotropic incompetence has not been rigorously defined. A conservative approach, supported by the literature, defines chronotropic incompetence as the failure to achieve an intrinsic heart rate of 70% of the age-predicted maximum heart rate or 120 bpm during exercise testing, whichever is less, where the age-predicted heart rate is calculated as 197 (0. 56 x age). Dual-chamber pacing (dual-chamber pulse generators) is indicated for those patients exhibiting:1) sick sinus syndrome2)chronic, symptomatic second- and third-degree av block3) recurrent adams-stokes syndrome; and4) symptomatic bilateral bundle branch block when tachyarrhythmia and other causes have been ruled out. Atrial pacing is indicated for patients with sinus node dysfunction and normal av and intraventricular conduction systems. Ventricular pacing is indicated for patients with significant bradycardia and:1) normal sinus rhythm with only rare episodes of a-v block or sinus arrest2) chronic atrial fibrillation; and 3) severe physical disabilityaf suppression (dual-chamber pulse generators) is indicated for suppression of paroxysmal or persistent atrial fibrillation episodes in patients with one or more of the above pacing indications. The tendril mri lead is a 7. 9 french, transvenous, steroid eluting, bipolar, is-1 compliant active fixation lead designed for permanent sensing and pacing in either the right atrium or the right ventricle, in combination with a compatible device. Active fixation leads such as the tendril mri lead may be indicated for patients where permanent fixation of passive fixation leads is suspected to be unstable. In atrial applications, the use of screw-in leads such as tendril mri lead may be indicated in the presence of an abnormal, surgically altered or excised atrial appendage. The mri activator handheld device is used to evaluate the status of, and to enable and disable, the previously stored mri settings. The activator is intended for use with st. Jude medical mr conditional pulse generators.

DeviceAssurity MRI and Endurity MRI Pacemakers, Tendril MRI Lead, MRI Activator, Merlin PCS Programer Software
Classification NameImplantable Pulse Generator, Pacemaker (non-crt)
Generic NameImplantable Pulse Generator, Pacemaker (non-crt)
ApplicantSt. Jude Medical, Inc.
Date Received2014-12-24
Decision Date2017-01-31
Notice Date2017-03-10
PMAP140033
SupplementS
Product CodeLWP
Docket Number17M-0661
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product Yes
Applicant Address St. Jude Medical, Inc. 15900 Valley View Court sylmar, CA 91342
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140033Original Filing
S076 2022-09-08 Real-time Process
S075 2022-07-27 Real-time Process
S074 2022-07-14 30-day Notice
S073 2022-07-01 30-day Notice
S072 2022-03-07 Real-time Process
S071 2021-10-18 Real-time Process
S070 2021-07-08 Normal 180 Day Track
S069 2021-06-28 30-day Notice
S068
S067 2021-04-02 Real-time Process
S066 2021-03-12 30-day Notice
S065
S064 2020-11-25 30-day Notice
S063 2020-10-21 30-day Notice
S062
S061 2020-09-30 30-day Notice
S060
S059 2020-05-22 30-day Notice
S058 2020-04-24 30-day Notice
S057 2020-04-23 Normal 180 Day Track No User Fee
S056 2020-02-27 30-day Notice
S055 2020-02-13 30-day Notice
S054
S053 2019-12-10 30-day Notice
S052 2019-12-09 30-day Notice
S051 2019-11-25 30-day Notice
S050
S049
S048
S047 2019-09-26 30-day Notice
S046 2019-07-31 30-day Notice
S045 2019-05-01 30-day Notice
S044 2018-11-30 30-day Notice
S043 2018-11-23 30-day Notice
S042 2018-11-20 30-day Notice
S041 2018-10-29 Real-time Process
S040 2018-10-02 30-day Notice
S039 2018-10-01 30-day Notice
S038 2018-09-28 30-day Notice
S037 2018-09-04 30-day Notice
S036 2018-07-17 30-day Notice
S035 2018-07-02 30-day Notice
S034 2018-06-28 Normal 180 Day Track
S033 2018-06-20 Normal 180 Day Track
S032 2018-05-21 30-day Notice
S031
S030 2018-05-01 30-day Notice
S029 2018-04-10 30-day Notice
S028 2018-04-05 30-day Notice
S027 2018-02-27 30-day Notice
S026 2018-02-07 30-day Notice
S025 2018-01-31 30-day Notice
S024 2018-01-29 30-day Notice
S023 2018-01-22 Real-time Process
S022 2018-01-18 Normal 180 Day Track
S021
S020 2017-11-29 30-day Notice
S019 2017-11-08 Real-time Process
S018 2017-11-07 Normal 180 Day Track
S017 2017-10-30 Real-time Process
S016 2017-10-10 30-day Notice
S015 2017-09-21 30-day Notice
S014 2017-09-18 135 Review Track For 30-day Notice
S013 2017-08-16 30-day Notice
S012 2017-08-01 Real-time Process
S011 2017-07-31 30-day Notice
S010 2017-07-03 Normal 180 Day Track
S009 2017-06-30 30-day Notice
S008 2017-05-17 Normal 180 Day Track
S007 2017-04-06 30-day Notice
S006 2017-04-03 Normal 180 Day Track
S005 2017-03-06 30-day Notice
S004 2017-02-28 30-day Notice
S003 2017-02-24 30-day Notice
S002 2017-02-17 135 Review Track For 30-day Notice
S001 2017-02-08 30-day Notice

NIH GUDID Devices

Device IDPMASupp
05414734509602 P140033 000
05414734509596 P140033 000
05414734509589 P140033 000
05414734509572 P140033 000
05414734504683 P140033 000
05414734504638 P140033 000
05414734504621 P140033 000
05414734503648 P140033 000
05414734510059 P140033 012

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.